Evidence map›Paper›PMID 38505381›Full record

ArticlePeerJ2023

Circular RNA hsa_circ_0051246 acts as a microRNA-375 sponge to promote the progression of gastric cancer stem cells

Minghui Deng, Yefeng Xu, Yongwei Yao, Yiqing Wang, Qingying Yan, Miao Cheng, YunXia Liu

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Minghui DengDepartment of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Yefeng XuDepartment of Oncology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
Yongwei YaoDepartment of Oncology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
Yiqing WangDepartment of Oncology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
Qingying YanDepartment of Oncology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
Miao ChengDepartment of Oncology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
YunXia LiuDepartment of Oncology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
Third People's Hospital of Hangzhou · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastric cancer (GC) stem cells play an important role in GC progression. Circular RNAs (circRNAs) act as microRNA (miRNA) sponges and inhibit the biological function of miRNAs in GC cytoplasm. MiRNAs also participate in GC progress. circ_0051246 was shown to be associated with miR-375 after analyzing GC microarray data GSE78091 and GSE83521. The oncoprotein Yes-associated protein 1 (YAP1) is targeted by miR-375 and can be inactivated Methods: SGC-7901 CSCs were used to establish knockdown/overexpression models of circ_0051246, miR-375, and YAP1. Malignant phenotypes of CSCs were assessed using Cell Counting Kit 8, colony/sphere formation, 5-Ethynyl-2'-deoxyuridine assay, flow cytometry, Transwell, and wound healing assays. To detect the interactions between circ_0051246, miR-375, and YAP1 in CSCs, a dual-luciferase reporter assay and fluorescence Results: Circ_0051246 silencing reduced viability, promoted apoptosis, and inhibited proliferation, migration and invasion of CSCs. The functional effects of miR-375 mimics were comparable to those of circ_0051246 knockdown; however, the opposite was observed after miR-375 inhibitors treatment of CSCs. Furthermore, circ_0051246-overexpression antagonized the miR-375 mimics' effects on CSCs. Additionally, YAP1 overexpression promoted CSC features, such as self-renewal, migration, and invasion, inhibited apoptosis and E-cadherin levels, and upregulated the expression of N-cadherin, vimentin, YAP1, neurogenic locus notch homolog protein 1, and jagged canonical notch ligand 1. Conversely, YAP1-silenced produced the opposite effect. Moreover, miR-375 treatment antagonized the malignant effects of YAP1 overexpression in CSCs. Importantly, circ_0051246 knockdown and miR-375 activation suppressed CSC tumorigenicity Conclusion: This study highlights the promotion of circ_0051246-miR-375-YAP1 axis activation in GC progression and provides a scientific basis for research on the molecular mechanism of CSCs.

Indexed as

MicroRNAsNeoplasmsAdaptor Proteins, Signal TransducingAnimalsHumansIn Situ Hybridization, FluorescenceMiceMice, NudeRNA, CircularTranscription FactorsYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingMicroRNAsMIRN375 microRNA, humanMirn375 microRNA, mouseRNA, CircularTranscription FactorsYAP1 protein, humanYap1 protein, mouseYAP-Signaling ProteinsCancer stem cellscirc_0051246Circular RNAGastric cancermicroRNAmiR-375Notch signaling pathway

Identifiers

PMID38505381
PMCPMC10950207
OpenAlexW4389200210

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.